AdynerinCAS# 35109-93-4 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 35109-93-4 | SDF | Download SDF |
PubChem ID | 441840 | Appearance | Powder |
Formula | C30H44O7 | M.Wt | 516.68 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC1C(C(CC(O1)OC2CCC3(C(C2)CCC45C3CCC6(C4(O5)CCC6C7=CC(=O)OC7)C)C)OC)O | ||
Standard InChIKey | BYZQVAOKDQTHHP-QFUJVLJYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Standard reference |
Structure Identification | Helvetica Chimica Acta.1963;46(1):374–392.Die Konstitution von Adynerin. Glykoside und Aglykonc, 245. Mitteilung.[Reference: WebLink]
|
Adynerin Dilution Calculator
Adynerin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9354 mL | 9.6772 mL | 19.3543 mL | 38.7087 mL | 48.3858 mL |
5 mM | 0.3871 mL | 1.9354 mL | 3.8709 mL | 7.7417 mL | 9.6772 mL |
10 mM | 0.1935 mL | 0.9677 mL | 1.9354 mL | 3.8709 mL | 4.8386 mL |
50 mM | 0.0387 mL | 0.1935 mL | 0.3871 mL | 0.7742 mL | 0.9677 mL |
100 mM | 0.0194 mL | 0.0968 mL | 0.1935 mL | 0.3871 mL | 0.4839 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- H-D-His-OH
Catalog No.:BCC2959
CAS No.:351-50-8
- Dendocarbin A
Catalog No.:BCN5287
CAS No.:350986-74-2
- Isodemethylwedelolacton
Catalog No.:BCN2766
CAS No.:350681-33-3
- 4-Epi-curcumenol
Catalog No.:BCN3523
CAS No.:350602-21-0
- Obscuraminol B
Catalog No.:BCN1766
CAS No.:350485-82-4
- Obscuraminol F
Catalog No.:BCN1768
CAS No.:350485-01-7
- Obscuraminol E
Catalog No.:BCN1769
CAS No.:350485-00-6
- Obscuraminol D
Catalog No.:BCN1770
CAS No.:350484-99-0
- Obscuraminol C
Catalog No.:BCN1767
CAS No.:350484-95-6
- 2,5-Dihydroxyxanthone
Catalog No.:BCN7573
CAS No.:35040-32-5
- ent-17-Hydroxykaur-15-en-19-oic acid
Catalog No.:BCN4644
CAS No.:35030-38-7
- Brosimacutin G
Catalog No.:BCN3202
CAS No.:350221-50-0
- GNTI dihydrochloride
Catalog No.:BCC7003
CAS No.:351183-88-5
- Blasticidin S HCl
Catalog No.:BCC5565
CAS No.:3513-03-9
- Deacylmetaplexigenin
Catalog No.:BCC8163
CAS No.:3513-04-0
- 5-Nonadecylresorcinol
Catalog No.:BCN7629
CAS No.:35176-46-6
- Isopropylidenylacetyl-marmesin
Catalog No.:BCN6792
CAS No.:35178-20-2
- INCA-6
Catalog No.:BCC2462
CAS No.:3519-82-2
- D-Tetrahydropalmatine
Catalog No.:BCN2334
CAS No.:3520-14-7
- JC-1
Catalog No.:BCC1669
CAS No.:3520-43-2
- AY-NH2
Catalog No.:BCC3949
CAS No.:352017-71-1
- 4,5-Dimethoxy-1-cyanobenzocyclobutane
Catalog No.:BCC8665
CAS No.:35202-54-1
- Ipriflavone (Osteofix)
Catalog No.:BCC5323
CAS No.:35212-22-7
- Neobyakangelicol
Catalog No.:BCN5288
CAS No.:35214-82-5
Die Konstitution von Adynerin. Glykoside und Aglykonc, 245. Mitteilung.
Helvetica Chimica Acta.1963;46(1):374–392.
The structure of adynerigenin as 3β-hydroxy-8,14β-epoxy-.5β-carda-20: 22-enolide (XIV) has been established by degradation and partial synthesis. Adynerin is the corresponding β-d-diginoside (VII).